$DAVA Income Statement | Understand Stock

$DAVA

$1.96 -$0.09 (4.39%) Close

Financial Statements

In millions of GBP; shares in millions, except per-share amounts

	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021
Revenue from contracts with customers
Cost of sales
Direct cost of sales
Allocated cost of sales
Total cost of sales
Gross profit
Selling, general and administrative expenses
Net impairment losses on financial assets
Operating profit
Finance expense
Finance income
Net finance (expense)/income
Gain on sale of subsidiary
Profit before tax
Tax on profit on ordinary activities
Profit for the year and profit attributable to the equity holders of the Company
Other comprehensive expense
Items that may be reclassified subsequently to profit or loss:
Exchange differences on translating foreign operations and net investment hedge impact
Total comprehensive (expense)/income for the year attributable to the equity holders of the Company
Earnings per share (EPS):
Basic EPS (in gbp per share)
Diluted EPS (in gbp per share)
Weighted average number of shares outstanding - basic (in shares)
Weighted average number of shares outstanding - diluted (in shares)

Comments